[go: up one dir, main page]

FI810971L - Substituerade acylderivat av oktahydro-1h-indol-2-karboxylsyror - Google Patents

Substituerade acylderivat av oktahydro-1h-indol-2-karboxylsyror

Info

Publication number
FI810971L
FI810971L FI810971A FI810971A FI810971L FI 810971 L FI810971 L FI 810971L FI 810971 A FI810971 A FI 810971A FI 810971 A FI810971 A FI 810971A FI 810971 L FI810971 L FI 810971L
Authority
FI
Finland
Prior art keywords
carboxylsyror
acylderivat
oktahydro
indol
substitute
Prior art date
Application number
FI810971A
Other languages
English (en)
Other versions
FI76072B (fi
FI76072C (fi
Inventor
Milton L Hoefle
George Bobowski
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/233,940 external-priority patent/US4350704A/en
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of FI810971L publication Critical patent/FI810971L/fi
Priority to FI854743A priority Critical patent/FI76560C/fi
Publication of FI76072B publication Critical patent/FI76072B/fi
Application granted granted Critical
Publication of FI76072C publication Critical patent/FI76072C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI810971A 1980-04-02 1981-03-30 Foerfarande foer framstaellning av terapeutiskt verkande oktahydro-1-( -merkaptoalkanoyl)-1h-indol-2- karboxylsyrafoereningar. FI76072C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI854743A FI76560C (fi) 1980-04-02 1985-11-29 Foerfarande foer framstaellning av farmaceutiskt anvaendbar 1-/2-/(1-karbetoxi-3-fenylpropyl)amino/-1- oxopropyl/-oktahydro-1h-indol-2-karboxylsyra.

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US13710680A 1980-04-02 1980-04-02
US13710680 1980-04-02
US19430780A 1980-10-06 1980-10-06
US19430780 1980-10-06
US06/233,940 US4350704A (en) 1980-10-06 1981-02-17 Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
US23394081 1981-02-17

Publications (3)

Publication Number Publication Date
FI810971L true FI810971L (fi) 1981-10-03
FI76072B FI76072B (fi) 1988-05-31
FI76072C FI76072C (fi) 1988-09-09

Family

ID=27384960

Family Applications (1)

Application Number Title Priority Date Filing Date
FI810971A FI76072C (fi) 1980-04-02 1981-03-30 Foerfarande foer framstaellning av terapeutiskt verkande oktahydro-1-( -merkaptoalkanoyl)-1h-indol-2- karboxylsyrafoereningar.

Country Status (14)

Country Link
EP (1) EP0037231B1 (fi)
KR (2) KR850000302B1 (fi)
AU (1) AU543861B2 (fi)
CA (1) CA1205476A (fi)
DE (1) DE3175875D1 (fi)
DK (2) DK157851C (fi)
ES (2) ES8206474A1 (fi)
FI (1) FI76072C (fi)
HK (1) HK30489A (fi)
IE (1) IE52663B1 (fi)
IL (1) IL62294A (fi)
NO (1) NO156609C (fi)
NZ (1) NZ196704A (fi)
SG (1) SG3889G (fi)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599357A (en) * 1979-12-17 1986-07-08 Ciba-Geigy Corporation 1-mercaptoalkanoylindoline-2-carboxylic acids
EP0278530A3 (de) * 1980-08-30 1989-08-02 Hoechst Aktiengesellschaft Aminosäurederivate, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und deren Verwendung
FR2492381A1 (fr) * 1980-10-21 1982-04-23 Science Union & Cie Nouveaux acides aza bicyclo alcane carboxyliques substitues leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
LU88621I2 (fr) * 1980-10-23 1995-09-01 Schering Corp Sandopril
US4374847A (en) * 1980-10-27 1983-02-22 Ciba-Geigy Corporation 1-Carboxyalkanoylindoline-2-carboxylic acids
GB2086390B (en) * 1980-11-03 1984-06-06 Ciba Geigy Ag 1-carboxy-azaalkanoylindoline-2-carboxylic acids process for their manufacture pharmaceutical preparations containing these compounds and their therapeutic application
US4479963A (en) * 1981-02-17 1984-10-30 Ciba-Geigy Corporation 1-Carboxyalkanoylindoline-2-carboxylic acids
DE3276311D1 (en) * 1981-02-17 1987-06-19 Warner Lambert Co Octahydro-2-(omega-mercaptoalkanoyl)3-oxo-1h-isoindole-1-carboxylic acids and esters
DE3134933A1 (de) * 1981-09-03 1983-03-31 Hoechst Ag, 6230 Frankfurt "harnstoffderivate, verfahren zu ihrer herstellung und diese enthaltende medikamente sowie deren verwendung"
DE3226768A1 (de) * 1981-11-05 1983-05-26 Hoechst Ag, 6230 Frankfurt Derivate der cis, endo-2-azabicyclo-(3.3.0)-octan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung
CA1341296C (en) * 1981-12-29 2001-09-25 Hansjorg Urbach 2-azabicycloalkane-3-carboxylic acid derivatives, processes for their preparation, agents containing these compounds and their use
ATE25244T1 (de) * 1981-12-29 1987-02-15 Hoechst Ag Neue derivate bicyclischer aminosaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie neue bicyclische aminosaeuren als zwischenstufen und verfahren zu deren herstellung.
DE3210496A1 (de) * 1982-03-23 1983-10-06 Hoechst Ag Neue derivate bicyclischer aminsaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie neue bicyclische aminosaeuren als zwischenstufen und verfahren zu deren herstellung
DE3211397A1 (de) * 1982-03-27 1983-11-10 Hoechst Ag, 6230 Frankfurt Spiro (4.(3+n))-2-aza-3-carbonsaeure-derivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung
DE3246503A1 (de) * 1982-12-16 1984-06-20 Hoechst Ag, 6230 Frankfurt Derivate der cis, endo-2-azabicyclo-(5.3.0)-decan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung
US5175306A (en) * 1983-01-31 1992-12-29 Hoechst Aktiengesellschaft Process for the resolution of racemates of optically active bicyclic imino-α-carboxylic esters
HU191120B (en) * 1983-01-31 1987-01-28 Hoechts Ag,De Process for raceme separation of optically active byciclic imino-alpha-carbonic acid esthers
DE3303344A1 (de) 1983-02-02 1984-08-02 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von n-alkylierten aminosaeuren und deren estern
DE3333455A1 (de) * 1983-09-16 1985-04-11 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung n-alkylierter dipeptide und deren estern
DE3333454A1 (de) * 1983-09-16 1985-04-11 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von n-alkylierten dipeptiden und deren estern
US5684016A (en) * 1984-04-12 1997-11-04 Hoechst Aktiengesellschaft Method of treating cardiac insufficiency
DE3413710A1 (de) * 1984-04-12 1985-10-24 Hoechst Ag, 6230 Frankfurt Verfahren zur behandlung der herzinsuffizienz
DE3431541A1 (de) * 1984-08-28 1986-03-06 Hoechst Ag, 6230 Frankfurt Cis,endo-2-azabicycloalkan-3-carbonsaeure-derivate, verfahren zu deren herstellung, deren verwendung sowie zwischenprodukte bei deren herstellung
US5231080A (en) * 1985-10-15 1993-07-27 Hoechst Aktiengesellschaft Method for the treatment of atherosclerosis, thrombosis, and peripheral vessel disease
US5231084A (en) * 1986-03-27 1993-07-27 Hoechst Aktiengesellschaft Compounds having a cognition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfuncitons
EP0254032A3 (en) 1986-06-20 1990-09-05 Schering Corporation Neutral metalloendopeptidase inhibitors in the treatment of hypertension
EP0566157A1 (en) 1986-06-20 1993-10-20 Schering Corporation Neutral metalloendopeptidase inhibitors in the treatment of hypertension
US4749688A (en) * 1986-06-20 1988-06-07 Schering Corporation Use of neutral metalloendopeptidase inhibitors in the treatment of hypertension
DE3633496A1 (de) * 1986-10-02 1988-04-14 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln
FR2605630B1 (fr) * 1986-10-22 1989-06-30 Roussel Uclaf Procede de preparation de derives de l'octahydroindole et intermediaires de preparation
DE3639879A1 (de) * 1986-11-21 1988-06-01 Hoechst Ag Verfahren zur herstellung von mono-, bi- und tricyclischen aminosaeuren, zwischenprodukte dieses verfahrens sowie ein verfahren zu deren herstellung
DE3641451A1 (de) * 1986-12-04 1988-06-16 Hoechst Ag Derivate bicyclischer aminocarbonsaeuren, verfahren und zwischenprodukte zu deren herstellung sowie deren verwendung
DE3722007A1 (de) * 1987-07-03 1989-01-12 Hoechst Ag Verfahren zur herstellung bicyclischer aminocarbonsaeuren, zwischenprodukte dieses verfahrens und deren verwendung
FR2620703B1 (fr) * 1987-09-17 1991-10-04 Adir Procede de synthese industrielle de l'acide perhydroindole carboxylique - 2(2s, 3as, 7as). application a la synthese de carboxyalkyl dipeptides
CA2522195A1 (en) * 2003-04-15 2004-10-28 Warner-Lambert Company Llc [b]-fused bicyclic proline derivatives and their use for treating arthritic conditions
SI21800A (sl) 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze perindoprila
EP1792896A1 (en) 2005-12-01 2007-06-06 KRKA, tovarna zdravil, d.d., Novo mesto Process for the preparation of perindopril and salts thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE608905R (fr) * 1960-12-19 1962-04-06 Bayer Ag Procédé de fabrication d'un composé agissant sur la tension sanguine.
DE1174781B (de) * 1960-12-24 1964-07-30 Bayer Ag Verfahren zur Herstellung von Salzen von 1-(Guanidinoalkyl)-pyrrolidinen
US4105776A (en) * 1976-06-21 1978-08-08 E. R. Squibb & Sons, Inc. Proline derivatives and related compounds
JPS5572169A (en) * 1978-11-27 1980-05-30 Tanabe Seiyaku Co Ltd Isoquinoline derivative and its preparation
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
US4461896A (en) * 1979-02-07 1984-07-24 Norwich Eaton Pharmaceuticals, Inc. 1-[Acylthio) and (mercapto)-1-oxoalkyl]-1,2,3,4-tetrahydroquinoline-2-carboxylic acids
DE3063420D1 (en) * 1979-03-26 1983-07-07 Takeda Chemical Industries Ltd Tetrahydroisoquinolines, their production and the compounds and pharmaceutical compositions containing them for use in the prevention or treatment of hypertension
US4303583A (en) * 1979-08-13 1981-12-01 American Home Products Corporation 1H,5H-[1,4]Thiazepino[4,3-a]indole-1,5-diones
DE2937779A1 (de) * 1979-09-19 1981-04-09 Hoechst Ag, 6000 Frankfurt Aminosaeurederivate und verfahren zu ihrer herstellung
FR2487829A2 (fr) * 1979-12-07 1982-02-05 Science Union & Cie Nouveaux imino acides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme

Also Published As

Publication number Publication date
KR850000302B1 (ko) 1985-03-18
EP0037231A3 (en) 1982-04-28
DK157851C (da) 1990-07-30
KR830005136A (ko) 1983-08-03
EP0037231A2 (en) 1981-10-07
NO811121L (no) 1981-10-05
DK148281A (da) 1981-10-03
NO156609C (no) 1987-10-21
DK157851B (da) 1990-02-26
ES500965A0 (es) 1982-08-16
IL62294A0 (en) 1981-05-20
EP0037231B1 (en) 1987-01-28
AU6893981A (en) 1981-10-08
HK30489A (en) 1989-04-21
DK159419C (da) 1991-03-18
ES8205771A1 (es) 1982-06-16
IE52663B1 (en) 1988-01-20
SG3889G (en) 1989-06-02
FI76072B (fi) 1988-05-31
KR850000303B1 (ko) 1985-03-18
FI76072C (fi) 1988-09-09
DK91088A (da) 1988-02-22
NZ196704A (en) 1984-12-14
IE810463L (en) 1981-10-02
DE3175875D1 (en) 1987-03-05
IL62294A (en) 1986-07-31
ES8206474A1 (es) 1982-08-16
AU543861B2 (en) 1985-05-09
ES504189A0 (es) 1982-06-16
NO156609B (no) 1987-07-13
CA1205476A (en) 1986-06-03
DK159419B (da) 1990-10-15
DK91088D0 (da) 1988-02-22

Similar Documents

Publication Publication Date Title
FI810971L (fi) Substituerade acylderivat av oktahydro-1h-indol-2-karboxylsyror
FI811041L (fi) Foerfarande foer framstaellning av mikrokapslar
FI803300L (fi) Anordning foer rullning av materialbanor
FI812243L (fi) Foerfarande foer framstaellning av sorelcement
FI813324L (fi) Foerfarande foer behandling av arsenikhaltiga avfall
FI810378L (fi) Anordning foer avskaerning av banor
FI801755A7 (fi) Framstaellning av en byggnadsplatta enligt upprullningsfoerfarandet
FI813775L (fi) Rengoering av cellulosa- och staerkelseetrar
FI811131L (fi) Anvaendning av alkylpolyglykoleterblandformaler foer foerhindrande av skumbildning
FI801597A7 (fi) Anordning foer tryckning av en aendloes materialbana
FI811948L (fi) Foerfarande foer skyddande av lyofiliserade betalaktamer fraon faergbildning
FI810917L (fi) Foerfarande foer framstaellning av en insulinprekursor
FI812273L (fi) Foerfarande foer oevervakning av mellanregeneratorer
FI812065L (fi) Foerfarande foer framstaellning av makrolid
FI810931L (fi) Anordning foer kontinuerlig centrering av en virkesbit
FI803289L (fi) Foerbaettrat foerfarande foer separering av normala paraffiner fraon kolvaeteblandningar
FI802649A7 (fi) Foerfarande foer framstaellning av kristalliskt simetidin
FI821294A0 (fi) Byggsats av stickklossar
FI813588L (fi) Brandtaetning av genomfoering foer ledning
FI811115L (fi) Foerfarande foer framstaellning av termoelastomeriska 3-blockblandpolymerisat
FI811015L (fi) Anordning foer reglering av fiberkoncentration
FI802848A7 (fi) Elektronisk taendare av lyslampa
FI803052A7 (fi) Foerfarande foer avlaegsning av skadliga foeroreningar fraon metallurgiska sulfidsmaeltor
FI813128L (fi) Foerfarande foer framstaellning av pektinesteraspreparat
FI813889L (fi) Foerfarande foer reglering av en traeslip

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: WARNER-LAMBERT COMPANY